Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Efficacy and Safety of Mircera in Chronic Renal Anemia
NCT00090753Phase 3Completed
- Sponsor
- Roche
- Start
- Oct 2004
- Primary completion
- Dec 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 27
01
Overview
A Phase 3 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Started Oct 2004; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00090753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090753.